InvestorsObserver
×
News Home

Affimed NV (AFMD) has risen 8.61% in a Week, Should You Accumulate?

Monday, November 22, 2021 10:01 AM | InvestorsObserver Analysts

Mentioned in this article

Affimed NV (AFMD) has risen 8.61% in a Week, Should You Accumulate?

The 52 rating InvestorsObserver gives to Affimed NV (AFMD) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 79 percent of stocks in the Biotechnology industry, AFMD’s 52 overall rating means the stock scores better than 52 percent of all stocks.

Overall Score - 52
AFMD has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on AFMD!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 52 would rank higher than 52 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Affimed NV Stock Today?

Affimed NV (AFMD) stock is lower by -2.53% while the S&P 500 has gained 0.78% as of 9:52 AM on Monday, Nov 22. AFMD has fallen -$0.17 from the previous closing price of $6.73 on volume of 4,514,742 shares. Over the past year the S&P 500 is up 32.34% while AFMD has gained 28.38%. AFMD lost -$0.51 per share the over the last 12 months. Click Here to get the full Stock Report for Affimed NV stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App